A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Modulation of apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations
Patent Number: U.S. Patent No. 9,593,333 B2 Filing Date: July 8, 2014 (U.S. application) Issue Date: March 14, 2017 Assignee: Ionis Pharmaceuticals, Inc. Expiration: Typically patent term extends 20 years from filing (around mid-2030s, subject…
-
Biodegradable lipids for the delivery of active agents
Patent Number: U.S. Patent No. 11,590,229 B2 Issue Date: February 28, 2023 Filing / Priority Dates: Claims priority to provisional filings circa December 7, 2011 and April 12, 2012 (typical for this family of patents)…
-
Methods of Treating Crohn’s Disease and Ulcerative Colitis
While AbbVie’s full immunology patent estate includes many related filings, one of the core U.S. composition-of-matter patents for upadacitinib underpins Rinvoq’s exclusivity. According to regulatory listings, patents covering upadacitinib (Rinvoq) include U.S. Patent No. 11,564,922…
